Ann: Imugene Corporate Presentation, page-220

First 220 Last

Share
Profile

Follow
JFlo

405 Posts.

49

23/07/23

21:05

Post #: 68935399
Share

Originally posted by Shaunbra: ↑

g’day JFlo

Any answer I provide can only be speculative as no one knows at this stage. People privy to the inner-workings of IMU might have a more substantial idea but at this stage all thoughts of an IMU 2.0 remain in a hypothetical space.

cashisking’s response hit the nail on the head, as they have provided a direct quote from LC. The pathways to value realisation include company acquisition, partnership with BP, and/or out-licensing of products. These seem fairly stock standard pathways and not unique to IMU. My view on the 2.0 comment is that Imugene could partner with BP and run as an arm / independent entity under ownership
of a BP company. It all remains to be seen.

Another note of caution that has come to mind today. Leslie mentioned during the presentation that even if a universal solution to treat cancer as one disease is achieved (ie. onCARlytics), they would still need trials and data for each individual cancer and treatment. Again, this will take time. Even if all solid tumours can be marked with a CD19 flag and treated (or even cured) with existing oncology products, each individual disease (cancer type) will require trials and data for regulatory approval. This reaffirms to me that the phase 1 Vaxinia trial has been designed in such a clever way (100 patients, 10+ clinical sites), with deep knowledge and experience of regulatory requirements, in order to achieve favourable FDA outcomes. This will
hopefully facilitate CF33 treatments to be approved (breakthrough therapy, fastrack) while concurrently conducting trials for each individual cancer type, saving lives of patients and providing a revenue source for shareholders. Very clever.

I remain excited and bullish towards the future achievements of IMU, with a renewed respect that these amazing achievements will take time.

Expand

Thanks a lot Shaunbra, greatly appreciated...

IMU Price at posting: 9.4¢ Sentiment: Buy Disclosure: Held
12 Upvote

0 Great analysis

Reply

Top Stories

ARN

Aldoro shares jump 47% on news of strong niobium recoveries from Namibia play

Week 28 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

RCE

Recce scores US$2M deal from US Department of Defense for burn wound infections gel

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Bitcoin investors need to know the risks

There are more pages in this discussion • 27 more messages in this thread...

First 220 Last

Add IMU (ASX) to my watchlist

(20min delay)
Last 5.7¢		Change -0.002(3.39%)		Mkt cap ! $440.9M

Open	High	Low	Value	Volume
6.0¢	6.2¢	5.7¢	$1.559M	26.12M

Buyers (Bids)

No.	Vol.	Price($)
15	939049	5.7¢

Sellers (Offers)

Price($)	Vol.	No.
5.8¢	856966	26

View Market Depth

No.	Vol.	Price($)
15	765946	0.057
15	2229522	0.056
23	3923845	0.055
11	2060287	0.054
6	411036	0.053

Price($)	Vol.	No.
0.058	860866	26
0.059	823029	11
0.060	1100609	7
0.061	461000	3
0.062	428348	5

Last trade - 13.12pm 15/07/2024 (20 minute delay)

IMU (ASX) Chart

Ann: Imugene Corporate Presentation, page-220

Aldoro shares jump 47% on news of strong niobium recoveries from Namibia play

Week 28 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Recce scores US$2M deal from US Department of Defense for burn wound infections gel

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Bitcoin investors need to know the risks

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Imugene Corporate Presentation, page-220

Top Stories

Aldoro shares jump 47% on news of strong niobium recoveries from Namibia play

Week 28 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Recce scores US$2M deal from US Department of Defense for burn wound infections gel

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Bitcoin investors need to know the risks

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News